Perimeter Medical Imaging AI (TSE:PINK) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Perimeter Medical Imaging AI has announced positive results from a clinical trial for its B-Series OCT system with ImgAssist AI 2.0, showing a significant reduction in residual cancer during breast-conserving surgeries compared to standard methods. This breakthrough could potentially lower reoperation rates and improve patient experiences, setting the stage for FDA approval in early 2025.
For further insights into TSE:PINK stock, check out TipRanks’ Stock Analysis page.
